1.3 Systemic Contraindications & Pharmacological Considerations

Systemic Contraindications & Pharmacological Considerations

Clinical Core: Manual therapy exerts profound mechanical, hemodynamic, and neurochemical effects on human physiology. Understanding the biological rationale underlying absolute contraindications, relative contraindications, and pharmacological interactions is essential to prevent adverse clinical events and ensure safe, defensible practice.

---

1. Safety Framework: The Spectrum of Contraindications

A contraindication is any medical condition, symptom, or physiological state that renders a particular medical or manual therapy intervention inadvisable because it could cause harm to the patient. In registered massage therapy, contraindications are classified along a clinical spectrum:

• Absolute Contraindications (Systemic / Universal): Any clinical situation in which massage therapy or manual manipulation is strictly forbidden anywhere on the patient's body. Applying manual techniques under these conditions carries a direct threat to patient health, such as mobilizing an embolus, exacerbating systemic infection, or inducing hemodynamic collapse.
• Relative Contraindications (Systemic Modifications Required): Conditions where manual therapy is permissible and often beneficial, but requires specific modifications to treatment variables—including depth of pressure, duration, pacing, positioning, hydrotherapy selection, and avoidance of aggressive techniques.
• Local Contraindications (Regional Avoidance): Conditions where a specific anatomical structure, quadrant, or limb must be completely avoided, while the remainder of the body can be safely and effectively treated.

Physiological Mechanisms of Treatment Harm

Manual therapy generates direct mechanical shearing forces, increases venous return and lymphatic flow, alters local and systemic vasomotor tone, stimulates autonomic reflex pathways, and influences neuroendocrine signaling. If applied indiscriminately, these physiological shifts can dislodge thrombi, spread virulent pathogens, rupture friable blood vessels, cause acute compartment bleeding, or compromise fragile skeletal architecture.

---

2. Absolute Contraindications in RMT Practice

When any of the following conditions are present, manual therapy must be withheld entirely, and the patient directed to appropriate medical care:

Acute Febrile Illness & Active Systemic Infection

• Clinical Presentation: Body temperature exceeding 38.0°C (100.4°F), accompanied by chills, rigors, diaphoresis, body aches, malaise, and systemic lethargy (e.g., active influenza, acute pneumonia, sepsis, bacteremia).
• Physiological Rationale: Massage therapy stimulates systemic circulation and metabolic turnover, placing an increased physiological demand on an already stressed cardiovascular and immune system. Furthermore, manual lymphatic stimulation during bacteremia or acute systemic infection risks accelerating the dissemination of pathogens.

Severe Acute Cardiovascular Emergencies & Instability

• Clinical Entities: Recent acute myocardial infarction (until the client's physician has cleared them), unstable angina pectoris, decompensated congestive heart failure (characterized by bilateral peripheral pitting edema, pulmonary rales, and orthopnea), and hypertensive crisis (systolic BP >180 mmHg or diastolic BP >120 mmHg).
• Physiological Rationale: Effleurage and centripetal circulatory strokes increase venous return to the right atrium (preload). In a compromised heart, this increased fluid volume can precipitate acute pulmonary edema, lethal arrhythmias, or cardiac decompensation.

Active Deep Vein Thrombosis (DVT) & Acute Thrombophlebitis

• Physiological Rationale: Mechanical pressure and shear stress can dislodge a fresh venous thrombus, causing it to travel through the inferior vena cava, right heart chambers, and lodge in the pulmonary arterial tree, resulting in a potentially fatal pulmonary embolism. Manual therapy is absolutely contraindicated across the entire body until the thrombus is fully resolved or medically stabilized under therapeutic anticoagulation with physician clearance.

Untreated / Unstable Aneurysms

• Clinical Entities: Large or unstable abdominal aortic aneurysms (AAA), thoracic aortic aneurysms, or known cerebral aneurysms.
• Physiological Rationale: Arterial walls in aneurysmal segments are pathologically thinned, fibrous, and vulnerable to catastrophic rupture from manual compressive forces or transient elevations in arterial pressure.

Acute Hemorrhage & Severe Coagulopathies

• Clinical Entities: Uncontrolled active internal bleeding, acute hemarthrosis, or severe hemophilia with active bleeding episodes. Any mechanical friction or compressive pressure exacerbates vascular extravasation and internal tissue hemorrhage.

Acute Systemic Intoxication

• Clinical Entities: Severe alcohol, recreational drug, or psychoactive medication intoxication.
• Physiological Rationale: Intoxication disrupts central pain perception, impairs cognitive ability to provide legal informed consent, and destabilizes vasomotor reflexes, predisposing the patient to profound orthostatic hypotension or physical injury.

---

3. Relative & Local Contraindications

Local Contraindications (Avoid Specific Anatomical Areas)

• Severe Varicose Veins & Venous Stasis Ulcers: Severe varicosities feature damaged, incompetent venous valves and weakened, tortuous vessel walls. Deep pressure, petrissage, or wringing over varicose veins can cause endothelial tearing, superficial thrombophlebitis, or dislodge microthrombi. Light, broad, soothing strokes proximal to the varicosities are permissible, but direct pressure on the enlarged veins is contraindicated.
• Acute Local Inflammation & Hematoma (First 24–72 Hours): Signs of acute inflammation (rubor, calor, tumor, dolor, functio laesa) from acute muscle strains, ligament sprains, or contusions contraindicate direct deep work. Deep friction can disrupt delicate platelet plugs, restart hemorrhage, and exacerbate secondary hypoxic tissue damage. Gentle proximal manual lymph drainage (MLD) and cold hydrotherapy are indicated.
• Localized Infectious & Contagious Skin Lesions: Impetigo, cellulitis, active herpes zoster (shingles), ringworm (tinea corporis), and active boils/furuncles. Direct contact is strictly contraindicated to prevent spreading the infection across the patient's body or cross-contaminating the clinic environment.
• Radiation Therapy Treatment Fields: Radiated skin suffers microvascular obliterative endarteritis, thinning of the dermis, extreme dryness, and diminished regenerative capacity. Deep tissue work, aggressive friction, and thermal hydrotherapy are locally contraindicated over irradiated skin. Furthermore, lymph node dissection associated with radiation creates permanent vulnerability to lymphedema.
• Recent Injection Sites:
  • Corticosteroid Injections: Avoid deep or frictional work over the injected tendon, bursa, or joint for the period the prescribing clinician advises (commonly about 2 weeks), because steroid exposure temporarily weakens collagen and raises the risk of tendon rupture.
  • Botulinum Toxin (Botox): Avoid manipulating injected muscles for the period the injecting clinician specifies, so the toxin is not spread to neighbouring muscles; there is no single universal waiting time.
  • Subcutaneous Insulin Sites: Ask when and where the client last injected and avoid massage or heat over that recent site, because local rubbing and heat speed insulin absorption and can provoke hypoglycemia.

Systemic Relative Contraindications (Modifications Required)

• Osteoporosis & Severe Osteopenia: Diminished bone mineral density elevates fracture risk. Modifications: Avoid rib springing, high-velocity joint mobilizations, aggressive spinal compression, and focal elbow pressure over ribs, clavicles, and femoral necks.
• Controlled Hypertension: Modifications: Avoid prolonged full-body heat hydrotherapy (which causes initial peripheral vasodilation followed by increased cardiac workload); avoid sudden positional transitions from recumbent to upright; avoid intense sustained isometric resistance testing.
• Pregnancy (Second & Third Trimesters): Modifications: Avoid prolonged supine positioning after 16–20 weeks of gestation due to supine hypotensive syndrome (compression of the inferior vena cava and descending aorta by the gravid uterus); utilize side-lying or semi-Fowler positioning with adequate pelvic and abdominal support. Modulate pressure over the medial lower leg and avoid deep pressure over the medial malleolus / Achilles area.

---

4. Pharmacology & Manual Therapy Interactions

Prescription and over-the-counter pharmaceuticals alter human physiology in ways that directly impact manual therapy. Therapists must understand the mechanisms of major drug classes, their clinical side effects, and the mandatory treatment modifications they necessitate.

Anticoagulants & Antiplatelets

• Medications: Warfarin (Coumadin), Direct Oral Anticoagulants (DOACs: Rivaroxaban [Xarelto], Apixaban [Eliquis], Dabigatran [Pradaxa]), Low-Molecular-Weight Heparins (Enoxaparin [Lovenox]), Antiplatelets (Clopidogrel [Plavix], Aspirin, Ticagrelor).
• Mechanism: Inhibit clotting cascade factors (e.g., thrombin, factor Xa, vitamin K epoxide reductase) or block platelet aggregation, dramatically prolonging clotting time.
• Clinical Risks: Extreme vulnerability to capillary rupture, petechiae, ecchymosis, extensive subcutaneous bruising, and deep intramuscular hematomas. In severe cases, deep tissue pressure can provoke acute compartment syndrome.
• RMT Modifications: Deep tissue stripping, deep cross-fiber frictions, aggressive myofascial release, heavy tapotement/percussion, and vigorous passive stretching are strictly contraindicated. Use light to moderate broad-contact effleurage and gentle petrissage. Never use focal elbow or knuckle pressure.

Corticosteroids (Systemic & Injectable)

• Medications: Prednisone, Methylprednisolone, Dexamethasone, Hydrocortisone, Triamcinolone (Kenalog).
• Mechanism: Potent anti-inflammatory and immunosuppressive actions via inhibition of phospholipase A2 and downstream prostaglandin/leukotriene cascades; suppresses fibroblast proliferation and collagen synthesis.
• Clinical Risks: Long-term systemic use causes dermal thinning, capillary fragility, accelerated ligamentous laxity, osteopenia, and severe tendon degradation (especially Achilles, patellar, and biceps tendons). Local corticosteroid injections weaken tendon architecture for several weeks.
• RMT Modifications: Defer deep or frictional work over a recent injection site for the period the prescriber advises (commonly about 2 weeks). For systemic users, avoid aggressive joint mobilizations, deep frictions over tendons, and high-load stretching. Use broad planar strokes and light to moderate pressure.

Analgesics, Opioids & NSAIDs

• Medications: Acetaminophen (Tylenol); Opioids: Morphine, Codeine, Oxycodone (OxyContin, Percocet), Hydromorphone (Dilaudid), Fentanyl; NSAIDs: Ibuprofen (Advil, Motrin), Naproxen (Aleve), Celecoxib (Celebrex), Diclofenac (Voltaren).
• Mechanism: NSAIDs inhibit cyclooxygenase (COX-1/COX-2), dampening peripheral inflammatory nociception; opioids stimulate central mu-opioid receptors, profoundly suppressing central pain perception; acetaminophen acts via central analgesic pathways.
• Clinical Risks: The patient's natural protective feedback loop is artificially blunted. Patients under the influence of peak medication cannot accurately perceive excessive pressure depth, leading to post-treatment tissue tearing, severe inflammation, and reactive muscle guarding.
• RMT Modifications: Determine the exact timing of the last dose. Schedule appointments when medication effects are minimal or at a stable baseline. Never rely on the patient's subjective tolerance to dictate pressure depth. Calibrate manual pressure conservatively using objective palpatory feedback and tissue end-feel.

Antihypertensives & Cardiovascular Medications

• Medications: Beta-blockers (Metoprolol, Atenolol, Propranolol), ACE Inhibitors (Ramipril, Lisinopril), ARBs (Losartan, Valsartan), Calcium Channel Blockers (Amlodipine, Diltiazem), Diuretics (Hydrochlorothiazide, Furosemide).
• Mechanism: Reduce blood pressure via arterial vasodilation, decreased cardiac contractility/heart rate, or reduced circulating plasma volume.
• Clinical Risks: Blunted baroreceptor reflex response. When a patient transitions from prolonged prone or supine recumbency to an upright seated or standing posture, cerebral perfusion temporarily drops, causing acute orthostatic hypotension, dizziness, vertigo, and syncope. Beta-blockers also blunt exercise- and heat-induced tachycardia.
• RMT Modifications: Avoid prolonged full-body hot hydrotherapy. Implement staged transitional positioning: have the patient sit on the edge of the treatment table for 1 to 2 minutes post-treatment, monitor for signs of lightheadedness or pallor, and ensure complete stability before ambulation.

Muscle Relaxants & Centrally Acting Antispasmodics

• Medications: Cyclobenzaprine (Flexeril), Baclofen, Methocarbamol (Robaxin), Diazepam (Valium).
• Mechanism: Depress polysynaptic spinal cord reflex arcs and central motor pathways, decreasing tonic alpha motor neuron firing.
• Clinical Risks: Systemic hypotonia, reduction of protective muscle splinting around injured joints, impaired proprioception, daytime drowsiness, and postural ataxia.
• RMT Modifications: Do not attempt aggressive passive joint stretching or vigorous mobilization, as the patient's protective muscular barriers are pharmacologically suppressed, risking ligamentous over-stretching. Focus on gentle neuromuscular relaxation and monitor balance post-treatment.

Insulin & Oral Hypoglycemic Agents

• Medications: Injectable Insulins (Humalog, NovoLog, Lantus, Levemir), Metformin, Sulfonylureas (Glyburide), GLP-1 Receptor Agonists (Semaglutide [Ozempic]).
• Mechanism: Facilitate cellular uptake of glucose, reduce hepatic gluconeogenesis, and enhance peripheral insulin sensitivity.
• Clinical Risks: Massage therapy stimulates circulation and promotes systemic parasympathetic relaxation, which can accelerate peripheral glucose utilization and trigger an unexpected hypoglycemic episode (sweating, tremors, palpitations, confusion, syncope). Massaging over recent injection sites alters insulin absorption kinetics.
• RMT Modifications: Ensure the patient has eaten a balanced meal or snack prior to treatment. Keep fast-acting oral carbohydrates (fruit juice, glucose tablets) readily accessible in the clinic room. Ask where and when insulin was last injected and avoid massage or heat over that site. Screen for diabetic peripheral neuropathy before applying thermal hydrotherapy.

---

5. Pharmacology Reference Matrix for Manual Therapy